Role of MRI for the detection of prostate cancer

Richard C. Wu; Amir H. Lebastchi; Boris A. Hadaschik; Mark Emberton; Caroline Moore; Pilar Laguna; Jurgen J. Fütterer; Arvin K. George

doi:10.1007/s00345-020-03530-3

Role of MRI for the detection of prostate cancer

Richard C. Wu
, Amir H. Lebastchi
, Boris A. Hadaschik
, Mark Emberton
, Caroline Moore
, Pilar Laguna
, Jurgen J. Fütterer
, Arvin K. George^*

^*Corresponding author for this work

I-Shou University
University of Southern California
German Cancer Research Center
University College London
Istanbul Medipol University
Radboud University Medical Center
University of Michigan, Ann Arbor

Research output: Contribution to journal › Article › Academic › peer-review

11 Downloads (Pure)

Abstract

The use of multiparametric MRI has been hastened under expanding, novel indications for its use in the diagnostic and management pathway of men with prostate cancer. This has helped drive a large body of the literature describing its evolving role over the last decade. Despite this, prostate cancer remains the only solid organ malignancy routinely diagnosed with random sampling. Herein, we summarize the components of multiparametric MRI and interpretation, and present a critical review of the current literature supporting is use in prostate cancer detection, risk stratification, and management.

Original language	English
Pages (from-to)	637-649
Number of pages	13
Journal	World journal of urology
Volume	39
Issue number	3
Early online date	2021
DOIs	https://doi.org/10.1007/s00345-020-03530-3
Publication status	Published - Mar 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

MRI
Prostate biopsy
Prostate cancer
Targeted biopsy

Access to Document

10.1007/s00345-020-03530-3

Role-of-mri-for-the-detection-of-prostate-cancer.pdfFinal published version, 1.3 MBLicence: Taverne

Cite this

@article{2793d3975645405bbe37f7fa00a29868,

title = "Role of MRI for the detection of prostate cancer",

abstract = "The use of multiparametric MRI has been hastened under expanding, novel indications for its use in the diagnostic and management pathway of men with prostate cancer. This has helped drive a large body of the literature describing its evolving role over the last decade. Despite this, prostate cancer remains the only solid organ malignancy routinely diagnosed with random sampling. Herein, we summarize the components of multiparametric MRI and interpretation, and present a critical review of the current literature supporting is use in prostate cancer detection, risk stratification, and management.",

keywords = "MRI, Prostate biopsy, Prostate cancer, Targeted biopsy",

author = "Wu, \{Richard C.\} and Lebastchi, \{Amir H.\} and Hadaschik, \{Boris A.\} and Mark Emberton and Caroline Moore and Pilar Laguna and F{\"u}tterer, \{Jurgen J.\} and George, \{Arvin K.\}",

note = "Funding Information: Mark Emberton receives research support from the United Kingdom{\textquoteright}s National Institute of Health Research (NIHR) UCLH / UCL Biomedical Research Centre. Publisher Copyright: {\textcopyright} 2021, Springer-Verlag GmbH Germany, part of Springer Nature. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = mar,

doi = "10.1007/s00345-020-03530-3",

language = "English",

volume = "39",

pages = "637--649",

journal = "World journal of urology",

issn = "0724-4983",

publisher = "Springer Verlag",

number = "3",

}

TY - JOUR

T1 - Role of MRI for the detection of prostate cancer

AU - Wu, Richard C.

AU - Lebastchi, Amir H.

AU - Hadaschik, Boris A.

AU - Emberton, Mark

AU - Moore, Caroline

AU - Laguna, Pilar

AU - Fütterer, Jurgen J.

AU - George, Arvin K.

N1 - Funding Information: Mark Emberton receives research support from the United Kingdom’s National Institute of Health Research (NIHR) UCLH / UCL Biomedical Research Centre. Publisher Copyright: © 2021, Springer-Verlag GmbH Germany, part of Springer Nature. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/3

Y1 - 2021/3

N2 - The use of multiparametric MRI has been hastened under expanding, novel indications for its use in the diagnostic and management pathway of men with prostate cancer. This has helped drive a large body of the literature describing its evolving role over the last decade. Despite this, prostate cancer remains the only solid organ malignancy routinely diagnosed with random sampling. Herein, we summarize the components of multiparametric MRI and interpretation, and present a critical review of the current literature supporting is use in prostate cancer detection, risk stratification, and management.

AB - The use of multiparametric MRI has been hastened under expanding, novel indications for its use in the diagnostic and management pathway of men with prostate cancer. This has helped drive a large body of the literature describing its evolving role over the last decade. Despite this, prostate cancer remains the only solid organ malignancy routinely diagnosed with random sampling. Herein, we summarize the components of multiparametric MRI and interpretation, and present a critical review of the current literature supporting is use in prostate cancer detection, risk stratification, and management.

KW - MRI

KW - Prostate biopsy

KW - Prostate cancer

KW - Targeted biopsy

UR - https://www.scopus.com/pages/publications/85098766397

U2 - 10.1007/s00345-020-03530-3

DO - 10.1007/s00345-020-03530-3

M3 - Article

C2 - 33394091

SN - 0724-4983

VL - 39

SP - 637

EP - 649

JO - World journal of urology

JF - World journal of urology

IS - 3

ER -

Role of MRI for the detection of prostate cancer

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this